Adaptive Biotechnologies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Adaptive Biotechnologies using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $-0.15 | $-0.15 | 0.00 % |
| Q2 | 2025-08-05 | $-0.17 | $-0.24 | 29.2 % |
| Q1 | 2025-05-01 | $-0.20 | $-0.31 | 35.5 % |
| Q4 | 2025-02-11 | $-0.23 | $-0.24 | 4.17 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $60.20M | $66.00M | -8.78 % |
| Q2 | 2025-08-05 | $58.88M | $49.52M | 18.9 % |
| Q1 | 2025-05-01 | $52.40M | $42.13M | 24.4 % |
| Q4 | 2025-02-11 | $47.46M | $46.05M | 3.06 % |
Adaptive Biotechnologies (ADPT) is scheduled to report earnings on February 10, 2026. The last reported earnings were for reported on November 5, 2025 for Q3.
The Actual EPS was $-0.15, which hit the estimate of $-0.15.
The Actual Revenue was $60.2M, which missed the estimate of $66M.
Browse earnings estimates, EPS, and revenue on all stocks.